IST

TgIST is a secreted dense granule effector of Toxoplasma gondii that traffics from intracellular parasites into the host cell nucleus, where it functions as a master antagonist of interferon-driven transcription to enable immune evasion (PMID:27503074, PMID:27414498). Within the nucleus it sequesters phosphorylated STAT1 on IFN-γ-responsive promoters and recruits the Mi-2/NuRD nucleosome-remodeling and deacetylase repressor complex, establishing a non-permissive chromatin state that blocks STAT1-dependent gene expression (PMID:27503074, PMID:27414498). This activity extends beyond IFN-γ: TgIST also suppresses type I IFN (IFN-β) signaling through STAT1/STAT2, and ΔTgist parasites show heightened susceptibility to both IFN-γ- and IFN-β-activated killing, with virulence restored in Ifnar1-/- mice (PMID:31413201). Mechanistically, TgIST is an intrinsically disordered protein whose internal repeat region folds into a helix upon engaging a groove on the STAT1 SH2 domain exposed by dimerization; it binds phosphorylated STAT1 dimers and, more avidly, tetramers, locking STAT1 in a DNA-bound, non-recycling state and blocking co-activator recruitment without displacing STAT1 from DNA (PMID:35831295, PMID:29968354). Functionally, TgIST represses effector genes including IDO1, PKR, MLKL, CIITA, and iNOS, thereby preventing tryptophan-starvation immunity and necroptotic host cell death and preserving the parasite's replicative niche in both tachyzoite and bradyzoite stages (PMID:30283439, PMID:34043960, PMID:34921775). TgIST operates as one of several nuclear-targeted, MYR1-dependent dense granule effectors that together are required for complete blockade of the human IFN-γ response (PMID:34921775, PMID:39292011).

1. 2011 Medium

   Before the effector was known, the question was how T. gondii silences IFN-γ responses; infection was shown to prevent chromatin remodeling at IFN-γ promoters, establishing that the block operates at the level of chromatin rather than upstream signaling.

   Evidence Transcriptomics, ChIP for BRG-1/histone acetylation, MS of GAS-bound complexes, and HDAC inhibitor rescue in infected macrophages

   PMID:22275866

   Open questions at the time

   • Did not identify the parasite effector responsible
   • Mechanism of NuRD/repressor recruitment not defined
2. 2013 Medium

   It was unknown how infection sustains STAT1 occupancy; ChIP and binding assays showed infection prevents STAT1 dissociation from DNA, blocking its recycling and establishing the STAT1-retention mechanism, while excluding rhoptries as the source of the effector.

   Evidence ChIP, STAT1-DNA binding assays, rhoptry injection without full invasion, and HDAC inhibitor treatment across three strain types

   PMID:24478085

   Open questions at the time

   • Effector identity still unknown
   • Did not distinguish dense granule origin directly
3. 2016 High

   Two concurrent studies identified TgIST as the secreted, nucleus-trafficking effector that sequesters STAT1 on IFN-γ loci and recruits the Mi-2/NuRD complex, directly linking a defined parasite protein to the chromatin-level block and demonstrating its role in virulence.

   Evidence Co-IP, ChIP, nuclear fractionation, ΔTgist deletion with phenotypic rescue, and mouse virulence/IFN-γ receptor-deficient rescue experiments

   PMID:27503074 PMID:27414498

   Open questions at the time

   • Structural basis of STAT1 binding not resolved
   • Whether other IFN pathways are targeted unaddressed
4. 2018 High

   The structural requirements of the STAT1 interaction were unknown; TgIST was shown to bind STAT1 tetramers more efficiently than dimers, require the STAT1 N-terminal domain and tetramerization, and increase STAT1 DNA affinity, explaining how STAT1 is retained in a phosphorylated DNA-bound state.

   Evidence Co-IP with STAT1 deletion/point mutants (F77A), EMSA, and nuclear retention assays

   PMID:29968354

   Open questions at the time

   • Atomic-resolution binding interface not defined
   • How binding excludes co-activators unresolved
5. 2018 Medium

   The downstream effector genes controlled were unclear; TgIST was shown to suppress IFN-γ-induced IDO1 in human cells, connecting STAT1 antagonism to blockade of tryptophan-starvation cell-autonomous immunity.

   Evidence ΔTgist infection, qPCR for IDO1, siRNA of IDO1/IDO2, and parasite growth assays in human cells

   PMID:30283439

   Open questions at the time

   • Limited mechanistic depth on IDO1 transcriptional suppression
   • Restricted to human cell context
6. 2019 High

   Whether TgIST acts only on IFN-γ was open; it was shown to also block type I IFN (IFN-β) STAT1/STAT2 signaling, broadening its role to both interferon arms of host defense.

   Evidence ΔTgist deletion, IFN-β stimulation, macrophage killing assays, and Ifnar1-/- mouse rescue

   PMID:31413201

   Open questions at the time

   • Whether STAT2-specific contacts differ from STAT1 not defined
7. 2020 Medium

   The evolutionary tuning of IST activity was addressed by comparing orthologs; T. gondii IST suppressed inflammatory responses more effectively than the Hammondia hammondi ortholog, correlating effector potency with the divergent host responses to each parasite.

   Evidence Co-infection, conditioned media transfer, transcriptomics, and functional comparison of T. gondii vs H. hammondi IST

   PMID:32574210

   Open questions at the time

   • Domain-level basis for functional divergence not mapped
   • Single-lab comparison
8. 2021 High

   How the parasite prevents host cell death was unclear; TgIST was shown to act with the bradyzoite effector TgNSM to block IFN-driven PKR and MLKL expression, preventing necroptosis and protecting the intracellular niche.

   Evidence Individual and combinatorial ΔTgist/ΔTgnsm deletion, MLKL phosphorylation and cell death readouts, and Co-IP of TgNSM with NCoR/SMRT

   PMID:34043960

   Open questions at the time

   • Direct role of TgIST versus TgNSM at PKR/MLKL promoters not separated
9. 2021 High

   Whether IST functions in the chronic stage was unknown; bradyzoites were shown to export IST in a MYR1-dependent manner to suppress IFN-γ signaling and protect host cells from IFN-γ-mediated death, establishing stage-independent function and defining the export route.

   Evidence Stage-specific ΔIST and ΔMYR1 bradyzoite deletion, transcriptomics, IFN reporter and cell death assays

   PMID:34921775

   Open questions at the time

   • Molecular details of MYR1-dependent translocation of IST not resolved
10. 2022 High

    The atomic mechanism of STAT1 inhibition was resolved; TgIST is intrinsically disordered and its repeat region folds into a helix upon binding a dimerization-exposed groove on the STAT1 SH2 domain, blocking co-activator recruitment without displacing STAT1 from DNA.

    Evidence X-ray crystallography, biochemical binding assays, mutagenesis of the TgIST repeat and STAT1 SH2 domain, and cellular reporter assays

    PMID:35831295

    Open questions at the time

    • How the DNA-bound complex physically recruits NuRD not structurally defined
11. 2024 High

    The sufficiency of TgIST alone was tested; genome-wide screens showed it is one of four nuclear-targeted dense granule effectors (with GRA16, GRA24, GRA28) collectively required for complete IFN-γ blockade, with loss of all four causing premature egress specifically in human cells.

    Evidence Genome-wide loss-of-function screens in IFNγ-primed human fibroblasts, combinatorial KOs, and egress/cell death assays in human vs murine cells

    PMID:39292011

    Open questions at the time

    • Individual contribution of TgIST within the four-effector set not quantified
    • Basis of human- versus murine-cell specificity unresolved
12. 2024 Medium

    Whether TgIST reduces STAT1 protein levels was tested in a heterologous system; stable TgIST expression in hepatocytes suppressed STAT1 and downstream IRF-1/NF-κB/CIITA/iNOS/chemokine expression and reduced pro-apoptotic markers, restoring cell viability.

    Evidence Stable TgIST transfection of Hepa-1c1c7 cells, western blot, RT-PCR, and flow cytometry for apoptosis markers

    PMID:38443768

    Open questions at the time

    • Heterologous expression outside the parasite context
    • No mechanistic dissection of how STAT1 protein levels fall
13. 2026 Medium

    Beyond IFN suppression, IST was placed within a broader effector network; it is one of eight MYR1-dependent dense granule effectors that additively activate non-canonical NF-κB signaling via TRAF3 depletion, NIK stabilization, and p100 processing, with no single effector solely responsible.

    Evidence Combinatorial KO panel, nuclear fractionation for RelB/p52, and western blot for NIK/p100/TRAF3 (preprint)

    PMID:41959509

    Open questions at the time

    • Preprint not yet peer-reviewed
    • Direct molecular role of IST in NF-κB activation not isolated from the other effectors

• How the DNA-bound TgIST-STAT1 complex physically recruits the NuRD repressor complex, and how TgIST contributes to broader effector networks such as non-canonical NF-κB activation, remain to be defined structurally and functionally.
• No structure of the TgIST-STAT1-NuRD bridging interaction
• Individual mechanistic contribution of IST within multi-effector networks not isolated